We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+31.13%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$3.89B
AUM Growth
+$2.3B
Cap. Flow
+$1.81B
Cap. Flow %
46.45%
Top 10 Hldgs %
13.13%
Holding
1,688
New
594
Increased
357
Reduced
244
Closed
486

Sector Composition

Rank Sector Weight
1 Technology 19.6%
2 Consumer Discretionary 13.23%
3 Financials 10.89%
4 Industrials 10.19%
5 Healthcare 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY.RT
451
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1.69M 0.04%
471,236
+130,936
+38% +$472K
MSI icon
452
Motorola Solutions
MSI
$72.6B
$1.68M 0.04%
12,007
-14,445
-55% -$2.04M
IQ icon
453
iQIYI
IQ
$1.26B
$1.68M 0.04%
72,400
-8,076
-10% -$150K
DIS icon
454
PUT
Walt Disney
DIS
$170B
$1.67M 0.04%
+15,000
New +$1.66M
GWPH
455
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1.67M 0.04%
+13,605
New +$1.54M
AXNX
456
DELISTED
Axonics, Inc. Common Stock
AXNX
$1.66M 0.04%
+47,296
New +$1.63M
TDS icon
457
Telephone and Data Systems
TDS
$3.92B
$1.66M 0.04%
83,300
+20,488
+33% +$392K
AGNC icon
458
AGNC Investment
AGNC
$12.6B
$1.65M 0.04%
128,139
+44,539
+53% +$559K
AIZ icon
459
Assurant
AIZ
$14B
$1.65M 0.04%
15,968
+9,316
+140% +$964K
BZUN
460
Baozun
BZUN
$175M
$1.65M 0.04%
+42,865
New +$1.35M
RAPT
461
DELISTED
RAPT Therapeutics
RAPT
$1.65M 0.04%
+7,093
New +$1.1M
FRC
462
DELISTED
First Republic Bank
FRC
$1.65M 0.04%
15,534
-9,166
-37% -$941K
MNTA
463
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.64M 0.04%
49,351
+34,596
+234% +$1.1M
AXSM icon
464
Axsome Therapeutics
AXSM
$10.9B
$1.64M 0.04%
19,886
+7,267
+58% +$559K
GNMK
465
DELISTED
GenMark Diagnostics, Inc
GNMK
$1.63M 0.04%
+110,829
New +$1.13M
FTCH
466
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$1.63M 0.04%
+94,211
New +$1.28M
HALO icon
467
Halozyme
HALO
$9.76B
$1.62M 0.04%
60,391
+32,686
+118% +$737K
BSX icon
468
Boston Scientific
BSX
$71.1B
$1.61M 0.04%
45,960
+16,482
+56% +$594K
KMI icon
469
Kinder Morgan
KMI
$69.9B
$1.6M 0.04%
105,829
+70,326
+198% +$1.07M
IHRT icon
470
iHeartMedia
IHRT
$602M
$1.6M 0.04%
+191,847
New +$1.49M
ORI icon
471
Old Republic International
ORI
$10.5B
$1.6M 0.04%
98,025
+71,625
+271% +$1.13M
LPX icon
472
Louisiana-Pacific
LPX
$5.37B
$1.6M 0.04%
+62,227
New +$1.32M
WYNN icon
473
Wynn Resorts
WYNN
$10.1B
$1.59M 0.04%
21,400
+10,827
+102% +$868K
TWOU
474
DELISTED
2U Inc
TWOU
$1.57M 0.04%
+1,383
New +$1.23M
GLIBA
475
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
$1.57M 0.04%
22,082
-3,218
-13% -$206K

Similar funds

Schonfeld Strategic Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Schonfeld Strategic Advisors held 1,688 positions worth $3.89B, up 145% from $1.59B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Schonfeld Strategic Advisors deployed $1.81B of net new capital in Q2 2020, opening 594 new positions and adding to 357 existing holdings. Its largest new stake was Claritev Corp: 75,000 shares worth $32.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was JD.com, an estimated $29.9M trimmed.

  • Schonfeld Strategic Advisors's largest Q2 2020 buy was Claritev Corp: 75,000 shares worth $32.4M.
  • Schonfeld Strategic Advisors added most to TC Energy in Q2 2020, an estimated $113M increase.
  • Schonfeld Strategic Advisors's biggest Q2 2020 reduction was JD.com, cutting an estimated $29.9M.
  • Schonfeld Strategic Advisors fully exited Allergan plc in Q2 2020, selling an estimated $37M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 13% of its $3.89B portfolio in Q2 2020.
  • Schonfeld Strategic Advisors opened 594 new positions and closed 486 in Q2 2020.
  • Schonfeld Strategic Advisors's portfolio value rose 145% quarter-over-quarter to $3.89B.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.